11 – 20 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Rationale and design of BROKEN-SWEDEHEART : a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome
Omerovic, Elmir ; James, Stefan ; Erlinge, David LU
; Hagström, Henrik
; Venetsanos, Dimitrios
; Henareh, Loghman
; Ekenbäck, Christina
; Alfredsson, Joakim
; Hambreus, Kristina
and Redfors, Björn
(2023)
In American Heart Journal
257.
p.33-40
- Contribution to journal › Article
-
Mark
Rationale and design of the DAPA-MI trial : Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
James, Stefan ; Erlinge, David LU
; Storey, Robert F.
; McGuire, Darren K.
; de Belder, Mark
; Björkgren, Ida
; Johansson, Peter A.
; Langkilde, Anna Maria
; Ridderstråle, Wilhelm
and Parvaresh Rizi, Ehsan
, et al.
(2023)
In American Heart Journal
266.
p.188-197
- Contribution to journal › Article
-
Mark
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival
- Contribution to journal › Article
- 2022
-
Mark
Rationale and design of switch Swedeheart : A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
Omerovic, Elmir ; Erlinge, David LU
; Koul, Sasha
LU
; Frobert, Ole
; Andersson, Jonas
LU
; Ponten, Johan
; Björklund, Fredrik
; Kastberg, Robert
; Petzold, Max
and Ljungman, Charlotta
, et al.
(2022)
In American Heart Journal
251.
p.70-77
- Contribution to journal › Article
- 2021
-
Mark
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
- Contribution to journal › Article
-
Mark
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction : Sex-related outcomes from DETO2X-AMI
Alfredsson, Joakim ; James, Stefan K. ; Erlinge, David LU
; Herlitz, Johan
; Fröbert, Ole
; Dworeck, Christian
; Redfors, Björn
; Arefalk, Gabriel
; Östlund, Ollie
and Jernberg, Tomas
, et al.
(2021)
In American Heart Journal
237.
p.13-24
- Contribution to journal › Article
-
Mark
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
Wärme, Jonatan ; Sundqvist, Martin ; Mars, Katarina ; Aladellie, Layth ; Pawelzik, Sven Christian ; Erlinge, David LU
; Jernberg, Tomas
; James, Stefan
; Hofmann, Robin
and Bäck, Magnus
(2021)
In American Heart Journal
231.
p.105-109
- Contribution to journal › Article
-
Mark
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT) : Rationale and design: MINOCA-BAT: Rationale and design
Nordenskjöld, Anna M. ; Agewall, Stefan ; Atar, Dan ; Baron, Tomasz ; Beltrame, John ; Bergström, Olle ; Erlinge, David LU
; Gale, Chris P.
; López-Pais, Javier
and Jernberg, Tomas
, et al.
(2021)
In American Heart Journal
231.
p.96-104
- Contribution to journal › Article
-
Mark
Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes : A prospective study
Bao, Xue LU ; Borné, Yan LU ; Xu, Biao ; Orho-Melander, Marju LU ; Nilsson, Jan LU ; Melander, Olle LU
and Engström, Gunnar
LU
(2021)
In American Heart Journal
234.
p.81-89
- Contribution to journal › Article
- 2020
-
Mark
Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
Østergaard, Lauge ; Pries-Heje, Mia Marie ; Hasselbalch, Rasmus Bo ; Rasmussen, Magnus LU
; Åkesson, Per
LU
; Horvath, Robert
; Povlsen, Jonas
; Gill, Sabine
; Bruun, Niels Eske
and Müllertz, Katrine
, et al.
(2020)
In American Heart Journal
227.
p.40-46
- Contribution to journal › Article